TVARDI THERAPEUTICS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-03-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-56.8% -$51M
$39M
Current Assets↓-72.7% -$84M
$32M
Cash & Equivalents↓-27.2% -$13M
$34M
ST Investments
—
Receivables↓-28.5% -$489K
$1M
Inventory↓-67.2% -$2M
$900K
Net PPE↓-97.5% -$3M
$84K
Intangibles
$385K
Total Liabilities↓-22.0% -$13M
$47M
Current Liabilities↓-92.1% -$14M
$1M
Account Payables↓-99.9% -$5M
$4K
Stockholders Equity↓-52.1% -$34M
$-101M
Retained Earnings↓-6.3% -$45M
$-761M
Operating Lease ROU Asset↓-100.0% -$4M
$0
Operating Lease Liability↓-100.0% -$7M
$0
Gross PP&E
$5M
Accumulated Depreciation
$2M
Inventory Raw Materials↓-0.8% -$18K
$2M
Inventory WIP↓-54.8% -$353K
$291K
Inventory Finished Goods
$4K
Contract Asset
—
Contract Liability
—
Contract Liability (Current)
—
Contract Liability (Noncurrent)
—
Remaining Performance Obligation
—